Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Refractory, with Excess of Blasts × Interleukin-2 × 90 days × Clear all

Sponsor

Conditions

Melanoma 8 Leukemia, Myeloid, Acute 5 Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Leukemia 3 Carcinoma, Non-Small-Cell Lung 3 Skin Neoplasms 2 Recurrence 2 Neoplasms 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Myeloid 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Colorectal Neoplasms 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urogenital Neoplasms 1 Stomach Neoplasms 1 Solid Tumor, Adult 1 Select Advanced Solid Tumors 1 Sarcoma 1 Prostatic Neoplasms 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1

Interventions

Cyclophosphamide 6 fludarabine 5 Mycophenolic Acid 5 Azacitidine 5 Whole-Body Irradiation 4 Tacrolimus 4 venetoclax 3 fludarabine phosphate 3 decitabine and cedazuridine drug combination 2 Vorinostat 2 Specimen Handling 2 Melphalan 2 Granulocyte Colony-Stimulating Factor 2 Busulfan 2 Biopsy 2 sulforaphane 1 ruxolitinib 1 enasidenib 1 cedazuridine 1 Triamcinolone 1 TAK-243 1 Stem Cell Transplantation 1 Sirolimus 1 Peripheral Blood Stem Cell Transplantation 1 Mesna 1 Lenalidomide 1 Hematopoietic Stem Cell Transplantation 1 Filgrastim 1 Cyclosporins 1 Cyclosporine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡